Key result
Olanzapine plus lithium achieves psychiatric stabilization following risperidone-induced QTc prolongation peaking at ~523 ms.
Why the study?
A baseline QTc of 500 ms in a patient with complex congenital heart disease significantly narrows the window for antipsychotic selection in first-episode psychosis.
Case Report (n=1)
This case demonstrates that individualized antipsychotic titration (ultimately olanzapine plus lithium), serial EKG monitoring, and multidisciplinary collaboration can achieve psychiatric stabilization in patients with complex congenital heart disease and baseline QTc prolongation.
Answers are grounded in this paper and cite their sources.
May guide individualized therapy in psychosis with congenital heart disease; leaves open prospective trials on QTc monitoring.
We present a male in his 20s with congenital heart defects, including dextrocardia, levo-transposition of the great arteries, Fontan physiology, and Wolff-Parkinson-White syndrome, who presented with first-episode psychosis. His baseline corrected QT interval (QTc) of 500 ms (Bazett) significantly narrowed the window for antipsychotic selection. Aripiprazole was initiated given its low QTc liability but produced no clinical improvement despite the lack of change in QTc. Risperidone was then given for its low risk of QTc-prolongation; however, the patient's QTc fluctuated and reached a peak at 523 ms (Bazett) and 490 ms (Fridericia) shortly after lithium was started with minimal symptomatic benefit. With lithium added for mood stabilization, the patient was cross tapered to olanzapine. Rhabdomyolysis, secondary to severe agitation and physical restraint, complicated the patient's clinical course. Ultimately, stabilization was achieved through slow medication titration, serial electrocardiograms (EKGs), and collaboration between psychiatry, cardiology, and pharmacy. This case highlights the need for individualized antipsychotic selection in structural heart disease and for improved risk stratification.
No takes yet. Share an insight, caveat, or question.
Stanley et al. (2026) conducted a case report in First-episode psychosis complicated by congenital heart disease (dextrocardia, levo-transposition of the great arteries, Fontan physiology, and Wolff-Parkinson-White syndrome) and baseline QTc prolongation (n=1). Sequential antipsychotic and mood stabilizer trials (aripiprazole, then risperidone with lithium, cross-tapered to olanzapine with lithium) was evaluated on Psychiatric stabilization and QTc interval monitoring. Olanzapine plus lithium achieved psychiatric stabilization after aripiprazole failed and risperidone with lithium peaked QTc at 523 ms (Bazett) from a 500 ms baseline.
Synapse has enriched 10 related papers. Consider them for comparative context: